Serina Therapeutics SER
NYSE SER
$1.78 +0.03 (+1.71%)
At close: Oct 22, 2026 · 4:00 PM EDT

Serina Therapeutics (SER) Construction in Progress (2019)

Updated

Serina Therapeutics (SER) posted Construction in Progress of $329,000 for Q3 2019, up 93.5% from the prior quarter.

Analysis

Serina Therapeutics (SER) Construction in Progress (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Serina Therapeutics 29.17 Mn -11.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 329,000.00
Jun 30, 2019 170,000.00
API Access

Serina Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=SER&period=max&api_key=YOUR_API_KEY